Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil

This study is ongoing, but not recruiting participants.

Sponsor:

Information provided by (Responsible Party):

Janssen Pharmaceutical K.K.

ClinicalTrials.gov Identifier:

NCT01478633

First received: November 3, 2011

Last updated: May 6, 2013

Last verified: May 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	December 2013
Estimated Primary Completion Date:	December 2013 (Final data collection date for primary outcome measure)